Intracoronary vasoactive therapy for no-reflow during primary PCI

19 February 2026 (08:00 - 18:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Federico Oliveri

Leiden University Medical Center, Leiden (Netherlands (The))

4 More presentations in this session

Presentation thumbnail

Differences in high-sensitivity troponin assay and association with myocardial injury and periprocedural MI after PCI for de novo three-vessel disease: insights from Multivessel TALENT

Doctor N. Kanehama (Galway, IE)

Abstract Slides

Presentation thumbnail

Cross-sectional analysis of primary PCI provision and AMI mortality across europe: accounting for economic and disease burden

Mr A. Malik (London, GB)

Abstract Slides

Presentation thumbnail

Breaking stereotypes: baseline features, treatment strategies, and 12-month outcomes in SCAD AMI patients: findings from the Serbian SCAD registry (SR SCAD)

Professor S. Apostolovic (Nis, RS)

Abstract Slides

Presentation thumbnail

Impact of different infusion routes in STEMI patients with high thrombotic risk

Doctor H. Tokdil (Istanbul, TR)

Abstract Slides

Access the full session

Session thumbnail

Contemporary PCI strategies in acute coronary syndromes: from diagnosis to optimisation

The Event

Event poster

EAPCI Summit 2026

19 February - 20 February 2026

You may be interested in

Congress Presentation

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Congress Presentation

State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources